Dear Oral Cancer & Diagnostics Insider,
The little yellow pills that have boosted men's sex lives for the past decade may soon help in the fight against head and neck cancer (HNC) and other diseases. In this Insider Exclusive, Donald Weed, MD, a professor of otolaryngology at the University of Miami, discusses clinical trials showing how tadalafil, commonly known by the brand name Cialis, can modulate the body's immune system, which could produce a new therapeutic strategy for head and neck squamous cell carcinoma (HNSCC).
In other Oral Cancer & Diagnostics Community news, post-treatment surveillance is a key factor in increasing survival rates in HNSCC patients. Click here to read how patients' income level and distance to medical centers are important components, according to a new study in JAMA Otolaryngology -- Head & Neck Surgery.
Meanwhile, using transoral robotic surgery alone could provide better quality of life and outcomes for patients with oropharyngeal squamous cell carcinoma. Read how the minimally invasive procedure can help these patients avoid chemotherapy or radiation completely, which also is discussed in JAMA Otolaryngology -- Head & Neck Surgery.
And a spice common in Indian and Asian cooking may have a therapeutic role in treating oral cancers associated with human papillomavirus (HPV), according to new research in the journal ecancermedicalscience. Click here to read what spice seems to suppress the activity of HPV.
Finally, a long-term analysis of a HNSCC study had surprising results. Read why practitioners who treat HNSCC patients who are also anemic should not add erythropoietin to their patient's radiation or chemotherapy care, according to a new study in the International Journal of Radiation Oncology, Biology, Physics.